Stock data

聿新科 (4161)

聿新科 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$47.69M, down 41.1% from a year earlier. EPS over the last four quarters totals NT$1.82.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 聿新科 in Insightr